Marco's Morning Report — Saturday, July 25, 2026

Section A — Top Stories

Update: Oil slips back under $100, but the war grinds on toward two weeks

The one bright spot since yesterday: after Brent punched through $100/bbl midweek on the Houthi Red Sea tanker strikes, prices dipped back below the century mark as traders bet the Bab el-Mandeb blockade is more rhetoric than sustained closure. The war itself hasn't cooled: the U.S. is now into roughly two weeks of nightly strikes, Iran is still hitting Gulf bases with drones, and Trump says he's weighing "a massive attack — bigger than ever before." AAA's national pump average is still hovering near $4/gal.

Why it's your business, Marco: the pullback in crude is the first thing that's gone your way on the commute in a week — but it's fragile. Watch Red Sea shipping headlines, not the airstrike count; that's the variable that actually moves the pump. The same oil chokehold is what's still crushing Cuba's grid (see Background).

A stack of quietly practice-changing guideline tweaks for your elderly admits

The Hospitalist's Updates in Clinical Guidelines roundup collects several small changes that hit exactly the patients you admit at 3 a.m. The ones worth pocketing: stop correcting calcium for albumin — use total or ionized calcium instead (the albumin correction is unreliable and drives needless workups). A complicated UTI is now defined by systemic signs — fever, chills, flank pain, distress beyond the bladder — which sharpens who actually needs the longer course. For a thrombocytopenic patient facing an LP or low-risk IR procedure, the transfusion threshold is platelets <20,000/µL. And in acute MI with anemia, the liberal strategy — transfuse toward Hgb >10 g/dL — is back in favor.

Practical takeaway: the calcium one is the freebie — it'll cut a few reflexive "corrected calcium" recalcs and ionized-calcium chases on your admits tonight. The complicated-UTI reframing is worth a glance at your unit's UTI order set next time it's up for review.

Section B — The Debate

Are Florida's insurance reforms actually fixing the market — or just stabilizing it for insurers?

Why it's live: regulators approved an average ~8.7% cut for personal lines effective July 1, and Citizens policyholders are seeing renewal reductions — the first broad price drop after years of brutal increases. DeSantis is touting it hard heading into the 2026 session; consumer advocates say "stabilizing" and "affordable" are two very different words. Same data, opposite conclusions.

For — the reforms are working

The 2022–23 tort and litigation overhaul killed the lawsuit machine that was gutting the market, and the numbers now show it: Florida's share of homeowners claims ending in litigation dropped sharply after the reform push, new carriers are entering, and rates are finally falling instead of spiking — the case DeSantis's office and industry groups make: fix the legal environment, and premiums follow.

Against — stabilizing ≠ affordable

A single-digit cut off a historically brutal base still leaves Floridians paying multiples of the national average — roughly $5,800–$8,300 a year on typical policies. Birny Birnbaum of the Center for Economic Justice calls the "market is stabilizing" framing "a sham," arguing new entrants lean on Citizens takeouts and affiliate reinsurance, and that tort reform mostly shielded insurers from claims — leaving homeowners to face lower payouts and more denials.

Where it might land: the 2026 legislative session is already circling bills (e.g., capping annual increases and beefing up the Insurance Consumer Advocate's powers) — the fight over whether "stabilized" is good enough plays out there.

Section C — On My Radar

Update — Mets, seller mode made official. David Stearns addressed reporters Friday before the Dodgers series, all but confirming the deadline plan: at ~43–59 and second-worst in the NL, the club is moving expiring pieces. Freddy Peralta already has multiple suitors; Clay Holmes could be dealt rather than extended; Lindor is unlikely to move. Deadline is Aug 3.

Age-friendly care, with receipts. A fresh crop of studies is putting numbers behind the 4Ms framework (What Matters, Medication, Mentation, Mobility) for hospitalized older adults — the kind of evidence that tends to show up in quality metrics before it shows up in mandates.

Frailty-adjusted glucose targets. A QI project on loosening inpatient glycemic targets for frail patients to prevent hypoglycemia — directly relevant to how tightly you run the sliding scale on your frail admits.

Golf tech: nothing genuinely new dropped this week. The current sub-$600 standout remains the Blue Tees Rainmaker ($599) with its 4.3" built-in color display — no phone needed for 20+ metrics.

Worth a watch: The Witness (Netflix, 100% critics) is still the strongest thing streaming; Silo S3 continues to land well if you want something you can pick back up.

Section D — Trends to Watch

A thin, jumpy oil market. Crude slipping back under $100 this week doesn't mean the buffer's rebuilt — Hormuz risk, the Red Sea, and a heavily drawn-down SPR mean prices can snap either direction on a single headline. Hurricane season stressing Gulf refining is the next stress test, and it hasn't arrived yet.

Geriatrics moving from "nice-to-have" to measured. The 4Ms and frailty-adjusted targets showing up in the literature together is a signal: age-friendly care is on the path from bedside best-practice to something hospitals get scored on. Worth being ahead of at your shop.

Section E — Ideas & Opportunities

Drop the albumin-corrected calcium habit tonight — smallest-effort, cleanest win on the list.

Next time your unit's UTI or glycemic order sets come up for review, bring the complicated-UTI reframe and the frailty-adjusted glucose targets to the table.

If you've been eyeing a practice monitor, the Blue Tees Rainmaker is the one to demo in the sub-$600 tier before you buy.

Keep half an eye on the Peralta/Holmes return package — that's the tell for whether this front office is rebuilding or just trimming payroll.

Section H — Background / Already Covered

Older or previously reported (tap to expand)

Cuba — grid still collapsing. Three nationwide blackouts in under two weeks earlier this month (~10M without power for 24hr+), driven by the U.S. oil chokehold and Cuba producing only ~40% of the fuel it needs. No new 48-hour development; the same oil story in Section A is the through-line. Al Jazeera.
USPSTF July meeting cancelled. Reported Thursday; no change since. Worth watching if you lean on Task Force preventive-care recs for discharge planning. AAFP.
SHM 2026 Workforce Report — AI adoption. 64% of hospitalists now use AI but only about a third feel adequately trained on it. Covered Thursday; a governance gap to keep an eye on.
Puerto Rico grid. No fresh 48-hour item; LUMA modernization work and the rate-relief/rate-hike fight continue in the background.
SSC 2026 sepsis guidelines. Standing reminder: MAP target of 65 mmHg holds generally, but the guideline notes older adults may benefit from lower targets — relevant to how you resuscitate elderly admits. SCCM.